Market Cap 589.48B
Revenue (ttm) 94.19B
Net Income (ttm) 26.80B
EPS (ttm) N/A
PE Ratio 22.46
Forward PE 20.83
Profit Margin 28.46%
Debt to Equity Ratio 0.46
Volume 16,316,700
Avg Vol 8,309,220
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 98%
Beta 0.26
Analysts Strong Sell
Price Target $259.88

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospit...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
chalz_joshua_
chalz_joshua_ Jun. 27 at 11:09 PM
$JNJ 🔥🔥📈
0 · Reply
Tetoooo
Tetoooo Jun. 27 at 10:55 PM
$JNJ I run triple AI models GPT, GIMINAI, and Claude to analyze this stock with http://TrioVate.ai it is free
0 · Reply
howardlindzon
howardlindzon Jun. 27 at 10:46 PM
$JNJ wow all time highs. bandaids
2 · Reply
CosmicMiner
CosmicMiner Jun. 27 at 10:37 PM
$JNJ has been incredibly strong, surging to $254.66 and hitting a new 52-week high! As a healthcare giant, its robust pharma pipeline and med-tech growth are drawing heavy defensive inflows. This rally looks solid.
1 · Reply
KryptonResearch
KryptonResearch Jun. 27 at 10:14 PM
While markets are extremely focused on the inputs to the AI trade (and for good reason, as this is where the capital is flowing at the present moment). We take a look at the flip side of the AI trade. Those using AI to accelerate their businesses. Today’s investment is one of our favorites. A great business and revolutionary technology, but more importantly, one that is going to transform the lives of billions. $LLY $NVO $ABBV $PFE $JNJ Take a read: https://kryptonresearch.substack.com/p/blood-money
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jun. 27 at 10:03 PM
Rotation is doing exactly what it usually does late-cycle- money stops chasing momentum and starts hiding in defensives with visible cash flows. This week the tape flipped hard: $ABBV +17% | pharma leadership catching bid on defensive + yield rotation $MRK +13% | large-cap healthcare strength as risk appetite fades $JNJ +12% | classic safety trade back in favor $DHR +11% | life sciences tools seeing steady institutional demand $LLY +10% | still strong structurally, but now part of broader defensive bid Meanwhile semis are cooling as AI beta unwinds from stretched positioning. This isn’t “AI is dead” pricing. It’s capital rotating from narrative to stability. When healthcare leads and semis lag, the market is telling you one thing: risk is being reduced, not added
0 · Reply
CapitalLogic1
CapitalLogic1 Jun. 27 at 9:07 PM
$JNJ still trending in a slow, steady way. No real volatility here, just consistent grinding higher without much attention. Moves feel orderly, more like a defensive name just doing its thing while the rest of the market swings around.
0 · Reply
WhaleTracker_
WhaleTracker_ Jun. 27 at 2:10 PM
This week’s tape rotation is pretty clear - AI and semis took a breather, while defensives quietly led. 1-week returns: $ABBV +17% (AbbVie) $MRK +13% (Merck) $JNJ +12% (Johnson & Johnson) $DHR +11% (Danaher) $LLY +10% (Eli Lilly) What stands out isn’t just performance, but leadership shifting into healthcare while high-beta growth cooled off. This kind of rotation usually says more about positioning stress than any single macro headline - when crowded trades unwind, capital doesn’t disappear, it just moves.
0 · Reply
Bjorgum
Bjorgum Jun. 27 at 1:05 PM
Healthcare starting to show real underlying strength here. Breakouts across $XBI and even $XLV approaching a key breakout level with breakouts on $JNJ and $ABBV. Even $GILD looks like it’s finding support after a long-term cup/base breakout. With semis extended, this could be an important defensive rotation to watch.
0 · Reply
FreedomQuestTrader
FreedomQuestTrader Jun. 26 at 9:59 PM
** 💎 TODAY's PREMIUM PLAYS:** ----------------------------------- - 🟩 $JNJ - 6/26 250C @ 1.21 --> 5.60 | **+362.81%** | **$439.00** - 🟩 $INOD - 7/17 90P @ 8.54 --> 18.55 | **+117.21%** | **$1001.00** - 🟥 $BG - 7/17 115C @ 2.10 --> 1.74 | **-17.00%** | **-$35.70** ────────────────── Total Trades: **4** Today's Winrate: **50.00%** Total Gains: **+423.02%** Average Gains Per Call: **+105.76%** Total Profits: **$1,108.30** ────────────────── *Unlock All Our Trading Alerts TODAY ➡️ [SIGN UP FOR FREEDOM QUEST TRADES](https://www.launchpass.com/freedom-quest-trades/premium-member) ⬅️ Gain full access to premium calls from top trading analysts and more!
0 · Reply
Latest News on JNJ
Johnson & Johnson presents first results from ENERGY study

2026-06-11T09:26:54.000Z - 16 days ago

Johnson & Johnson presents first results from ENERGY study


Johnson & Johnson to Buy Firefly Bio for $1 Billion

Jun 8, 2026, 9:01 AM EDT - 19 days ago

Johnson & Johnson to Buy Firefly Bio for $1 Billion


Johnson & Johnson to acquire Firefly Bio for $1B in cash

2026-06-08T12:14:56.000Z - 19 days ago

Johnson & Johnson to acquire Firefly Bio for $1B in cash


Johnson & Johnson to buy Firefly Bio for $1 billion

Jun 8, 2026, 8:08 AM EDT - 19 days ago

Johnson & Johnson to buy Firefly Bio for $1 billion


Johnson & Johnson says nipocalimab approved in China

May 21, 2026, 4:31 AM EDT - 5 weeks ago

Johnson & Johnson says nipocalimab approved in China


CVS to drop J&J's Stelara from its main formularies

May 5, 2026, 9:15 AM EDT - 7 weeks ago

CVS to drop J&J's Stelara from its main formularies

CVS


J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine

May 2, 2026, 4:00 AM EDT - 2 months ago

J&J's $1.7 Billion Drug Ushers in Age of Psychedelic Medicine


Why These 3 Forever Stocks Belong on Your Watchlist

Apr 28, 2026, 11:10 AM EDT - 2 months ago

Why These 3 Forever Stocks Belong on Your Watchlist

WMT XOM


J&J sees AI halving the time to generate drug development leads

Apr 27, 2026, 11:03 AM EDT - 2 months ago

J&J sees AI halving the time to generate drug development leads


chalz_joshua_
chalz_joshua_ Jun. 27 at 11:09 PM
$JNJ 🔥🔥📈
0 · Reply
Tetoooo
Tetoooo Jun. 27 at 10:55 PM
$JNJ I run triple AI models GPT, GIMINAI, and Claude to analyze this stock with http://TrioVate.ai it is free
0 · Reply
howardlindzon
howardlindzon Jun. 27 at 10:46 PM
$JNJ wow all time highs. bandaids
2 · Reply
CosmicMiner
CosmicMiner Jun. 27 at 10:37 PM
$JNJ has been incredibly strong, surging to $254.66 and hitting a new 52-week high! As a healthcare giant, its robust pharma pipeline and med-tech growth are drawing heavy defensive inflows. This rally looks solid.
1 · Reply
KryptonResearch
KryptonResearch Jun. 27 at 10:14 PM
While markets are extremely focused on the inputs to the AI trade (and for good reason, as this is where the capital is flowing at the present moment). We take a look at the flip side of the AI trade. Those using AI to accelerate their businesses. Today’s investment is one of our favorites. A great business and revolutionary technology, but more importantly, one that is going to transform the lives of billions. $LLY $NVO $ABBV $PFE $JNJ Take a read: https://kryptonresearch.substack.com/p/blood-money
0 · Reply
FibonacciTrader_
FibonacciTrader_ Jun. 27 at 10:03 PM
Rotation is doing exactly what it usually does late-cycle- money stops chasing momentum and starts hiding in defensives with visible cash flows. This week the tape flipped hard: $ABBV +17% | pharma leadership catching bid on defensive + yield rotation $MRK +13% | large-cap healthcare strength as risk appetite fades $JNJ +12% | classic safety trade back in favor $DHR +11% | life sciences tools seeing steady institutional demand $LLY +10% | still strong structurally, but now part of broader defensive bid Meanwhile semis are cooling as AI beta unwinds from stretched positioning. This isn’t “AI is dead” pricing. It’s capital rotating from narrative to stability. When healthcare leads and semis lag, the market is telling you one thing: risk is being reduced, not added
0 · Reply
CapitalLogic1
CapitalLogic1 Jun. 27 at 9:07 PM
$JNJ still trending in a slow, steady way. No real volatility here, just consistent grinding higher without much attention. Moves feel orderly, more like a defensive name just doing its thing while the rest of the market swings around.
0 · Reply
WhaleTracker_
WhaleTracker_ Jun. 27 at 2:10 PM
This week’s tape rotation is pretty clear - AI and semis took a breather, while defensives quietly led. 1-week returns: $ABBV +17% (AbbVie) $MRK +13% (Merck) $JNJ +12% (Johnson & Johnson) $DHR +11% (Danaher) $LLY +10% (Eli Lilly) What stands out isn’t just performance, but leadership shifting into healthcare while high-beta growth cooled off. This kind of rotation usually says more about positioning stress than any single macro headline - when crowded trades unwind, capital doesn’t disappear, it just moves.
0 · Reply
Bjorgum
Bjorgum Jun. 27 at 1:05 PM
Healthcare starting to show real underlying strength here. Breakouts across $XBI and even $XLV approaching a key breakout level with breakouts on $JNJ and $ABBV. Even $GILD looks like it’s finding support after a long-term cup/base breakout. With semis extended, this could be an important defensive rotation to watch.
0 · Reply
FreedomQuestTrader
FreedomQuestTrader Jun. 26 at 9:59 PM
** 💎 TODAY's PREMIUM PLAYS:** ----------------------------------- - 🟩 $JNJ - 6/26 250C @ 1.21 --> 5.60 | **+362.81%** | **$439.00** - 🟩 $INOD - 7/17 90P @ 8.54 --> 18.55 | **+117.21%** | **$1001.00** - 🟥 $BG - 7/17 115C @ 2.10 --> 1.74 | **-17.00%** | **-$35.70** ────────────────── Total Trades: **4** Today's Winrate: **50.00%** Total Gains: **+423.02%** Average Gains Per Call: **+105.76%** Total Profits: **$1,108.30** ────────────────── *Unlock All Our Trading Alerts TODAY ➡️ [SIGN UP FOR FREEDOM QUEST TRADES](https://www.launchpass.com/freedom-quest-trades/premium-member) ⬅️ Gain full access to premium calls from top trading analysts and more!
0 · Reply
GettnFibbywIT
GettnFibbywIT Jun. 26 at 9:06 PM
$JNJ Textbook
0 · Reply
TroyTiger
TroyTiger Jun. 26 at 8:51 PM
$TGTX This is trading like a stock about to be bought out. I still think $JNJ is the one, as their stock is at all-time highs.
2 · Reply
BreakoutLife
BreakoutLife Jun. 26 at 8:50 PM
Nasdaq just logged its 5th straight down session - and this one is clearly being driven by a rapid sentiment reset in AI + semis. The catalyst: reports that OpenAI may delay its IPO into next year. That single headline is now being interpreted as a signal that the pace of AI infrastructure financing could slow, not just a corporate timing issue. That’s where the spillover starts: $MU -4% $INTC -3% $AMD -2% SoftBank -12% in Tokyo Kospi -5.8% - broad Asia risk-off move What you’re seeing is not just stock-specific weakness - it’s a global de-risking of the AI capex trade, with JPMorgan even flagging potential sustainability concerns if capital markets funding slows. And as usual in late-cycle rotations, money isn’t leaving the market - it’s rotating: $LLY +7%, $JNJ +3%, defensives, staples, utilities all catching flows. Adding macro pressure: Kashkari signaling potential additional rate hike risk due to inflation tied to geopolitical shocks - which doesn’t help growth duration multiples either. Feels like one of those moments where the AI trade doesn’t break… it just gets repriced.
0 · Reply
notreload_ai
notreload_ai Jun. 26 at 7:54 PM
BREAKING: $ABBV, $LLY and $JNJ shares are on track to reach all-time highs.
0 · Reply
TalkMarkets
TalkMarkets Jun. 26 at 6:33 PM
Stocks Look To Reverse Losses And Finish Friday On High Note $HPE $JNJ $LYFT $NDX $SPX https://talkmarkets.com/article/stocks-look-to-reverse-losses-and-finish-friday-on-high-note-1782498738
0 · Reply
PittsburghTrader
PittsburghTrader Jun. 26 at 6:08 PM
$JNJ wow, didn’t expect this strength after getting a nice bid yesterday
0 · Reply
usiv
usiv Jun. 26 at 5:43 PM
$JNJ $LLY $ABBV looking to close monthly candle on high note
0 · Reply
focafoca99
focafoca99 Jun. 26 at 4:45 PM
$JNJ presented new IMAAVY data at the EAN 2026 Congress, showing sustained disease control in generalized myasthenia gravis. https://www.rapidticker.com/news/jnj-johnson-johnson-presents-new-imaavy-0ac67c
0 · Reply
BillionerOfKing
BillionerOfKing Jun. 26 at 4:35 PM
$JNJ Current Stock Price: $253.00 Contracts to trade: $252.5 JNJ Jun 26 2026 Call Entry: $0.94 Exit: $1.21 ROI: 29% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 3:20 PM
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 3:16 PM
$DJT $GME $JNJ Go Elite.... ELTP....
0 · Reply
BarkingPuppy
BarkingPuppy Jun. 26 at 3:15 PM
0 · Reply